Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | ACP3 | P15309 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | FBP1 | P09467 | 2/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.39 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.39 |
| ▸ | CACNB1 | Q02641 | 1/20 | 0.39 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.39 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.39 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6106703 | 0.80 | ACP3 (0.45) | MEN1KMT2AACP3ALDH1A1POLB | |
| SCHEMBL11526451 | 0.80 | HDAC4 (0.46) | FBP1CNR1 | |
| SCHEMBL74691 | 0.80 | SRC (0.48) | ALDH1A1TDP1LMNAMAPK1 | |
| SCHEMBL11322474 | 0.79 | CYP2C9 (0.41) | MEN1KMT2APOLBFBP1LMNA | |
| SCHEMBL11602886 | 0.78 | SRC (0.46) | ALDH1A1TDP1LMNAMAPK1 | |
| SCHEMBL11602507 | 0.78 | SRC (0.46) | ALDH1A1TDP1LMNAMAPK1 | |
| SCHEMBL887039 | 0.78 | SRC (0.46) | ALDH1A1TDP1LMNAMAPK1 | |
| SCHEMBL5631889 | 0.78 | HSD17B10 (0.43) | ALDH1A1LMNA | |
| SCHEMBL27814338 | 0.78 | PTGS1 (0.58) | ALDH1A1TDP1LMNAMAPTMAPK1 | |
| Hydrochloric Acid SCHEMBL11329800 | 0.77 | CYP2C9 (0.40) | MEN1KMT2APOLBFBP1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103105391-A | Novel mercapto color developing agent, preparation method and application thereof | UNIV CHONGQING MEDICAL | 2013-05-15 | — | — | CN | claimed |
| CN-103105391-A | Novel mercapto color developing agent, preparation method and application thereof | UNIV CHONGQING MEDICAL | 2013-05-15 | — | — | CN | disclosed |
| US-20060178426-A1 | Kappa agonists, especialy for the treatment and/or prophylaxis of irritable bowel syndrome | MERCK PATENT GMBH (DE) | 2006-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060178426-A1 | Kappa agonists, especialy for the treatment and/or prophylaxis of irritable bowel syndrome | OPRK1, ADRA2A, OPRD1 | MEN1 2340/4885KMT2A 671/4885ACP3 3173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.